Olopatadine use while Breastfeeding

Drugs containing Olopatadine: Pataday, Patanol, Pazeo, Patanase

Medically reviewed on September 7, 2017.

Olopatadine Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because absorption from the eye is limited, olopatadine would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Cromolyn

References

Olopatadine Identification

Substance Name

Olopatadine

CAS Registry Number

113806-05-6

Drug Class

Anti-Allergic Agents

Antihistamines

Administrative Information

LactMed Record Number

627

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer